Health CareHealth Care Equipment & Services
  • Price (ISK)460.00
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change19.48%
  • Beta0.6722
Data delayed at least 15 minutes, as of Nov 17 2017 15:29 GMT.
More ▼

Profile data is unavailable for this security.

About the company

Ossur hf is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. The Company is divided into three market segments: Bracing and Supports, which offers products for therapeutic and preventive purposes; Prosthetics, which offers products for amputees, which include sockets, sleeves, prosthetic knees and feet, as well as supporting components, and Compression Therapy, which offers treatment for venous ulcers and edema. The Company's main markets are North America, Europe and Asia. It has subsidiaries in Iceland, the United States, Canada, Mexico, France, the Netherlands, the United Kingdom, Sweden, Norway, Spain, South Africa, China and Australia.

  • Revenue in DKK (TTM)3.49bn
  • Net income in DKK308.66m
  • Incorporated1971
  • Employees2.80k
  • Location
    Ossur hfGrjothals 1-5REYKJAVIK 110IcelandISL
  • Phone+354 5151300
  • Fax+354 5151366
  • Websitehttp://www.ossur.com/
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.